CME Group, Inc. (CME) Tops Q2 EPS Views; Revs Strong
CME Group, Inc. (NASDAQ: CME) reported Q2 EPS of $4.38, $0.21 better than the analyst estimate of $4.17. Revenue for the quarter came in at $838 million versus the consensus estimate of $821.33 million.